dc.contributor.author | Harries, LW | |
dc.contributor.author | McCulloch, LJ | |
dc.contributor.author | Holley, JE | |
dc.contributor.author | Rawling, TJ | |
dc.contributor.author | Welters, HJ | |
dc.contributor.author | Kos, Katarina | |
dc.date.accessioned | 2016-02-12T09:04:02Z | |
dc.date.issued | 2013-06-28 | |
dc.description.abstract | AIMS/HYPOTHESIS: We have previously shown the implication of the multifunctional protein SPARC (Secreted protein acidic and rich in cysteine)/osteonectin in insulin resistance but potential effects on beta-cell function have not been assessed. We therefore aimed to characterise the effect of SPARC on beta-cell function and features of diabetes. METHODS: We measured SPARC expression by qRT-PCR in human primary pancreatic islets, adipose tissue, liver and muscle. We then examined the relation of SPARC with glucose stimulated insulin secretion (GSIS) in primary human islets and the effect of SPARC overexpression on GSIS in beta cell lines. RESULTS: SPARC was expressed at measurable levels in human islets, adipose tissue, liver and skeletal muscle, and demonstrated reduced expression in primary islets from subjects with diabetes compared with controls (p< = 0.05). SPARC levels were positively correlated with GSIS in islets from control donors (p< = 0.01). Overexpression of SPARC in cultured beta-cells resulted in a 2.4-fold increase in insulin secretion in high glucose conditions (p< = 0.01). CONCLUSIONS: Our data suggest that levels of SPARC are reduced in islets from donors with diabetes and that it has a role in insulin secretion, an effect which appears independent of SPARC's modulation of obesity-induced insulin resistance in adipose tissue. | en_GB |
dc.description.sponsorship | Diabetes Research Wellness Foundation | en_GB |
dc.identifier.citation | Vol. 8, Iss. 6, pp. e68253 - | en_GB |
dc.identifier.doi | 10.1371/journal.pone.0068253 | |
dc.identifier.other | PONE-D-13-03911 | |
dc.identifier.uri | http://hdl.handle.net/10871/19748 | |
dc.language.iso | en | en_GB |
dc.publisher | Public Library of Science | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/23840838 | en_GB |
dc.relation.url | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068253 | en_GB |
dc.rights | Copyright © 2013 Harries et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_GB |
dc.subject | Adipose Tissue | en_GB |
dc.subject | Adult | en_GB |
dc.subject | Cells, Cultured | en_GB |
dc.subject | Diabetes Mellitus | en_GB |
dc.subject | Female | en_GB |
dc.subject | Glucose | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Insulin | en_GB |
dc.subject | Insulin Resistance | en_GB |
dc.subject | Insulin-Secreting Cells | en_GB |
dc.subject | Islets of Langerhans | en_GB |
dc.subject | Liver | en_GB |
dc.subject | Male | en_GB |
dc.subject | Middle Aged | en_GB |
dc.subject | Muscles | en_GB |
dc.subject | Osteonectin | en_GB |
dc.title | A role for SPARC in the moderation of human insulin secretion. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2016-02-12T09:04:02Z | |
dc.identifier.issn | 1932-6203 | |
exeter.place-of-publication | United States | |
dc.description | Published online | en_GB |
dc.description | Journal Article | en_GB |
dc.description | Research Support, Non-U.S. Gov't | en_GB |
dc.identifier.journal | PLoS One | en_GB |